Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ye Ning

Showing results (71-80 of 75) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 75 results.
Vaccine|November 5, 2005
Preparation and characterization of SARS in-house reference antiserumJiansan Zhang, Yuxuan Liu, Liangxiang Hu, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|August 30, 2013
[Trastuzumab in combination with chemotherapy versus chemotherapy alone for first-line treatment of HER2-positive advanced gastric or gastroesophageal junction cancer: a Phase III, multi-center, randomized controlled trial, Chinese subreport]Lin Shen, Jian-ming Xu, Feng-yi Feng, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 27, 2007
Genome sequencing and comparative analysis of Saccharomyces cerevisiae strain YJM789Wu Wei, John H McCusker, Richard W Hyman, et al.
Vaccine|January 31, 2021
Recombinant SARS-CoV-2 RBD with a built in T helper epitope induces strong neutralization antibody responseQiu-Dong Su, Ye-Ning Zou, Yao Yi, et al.
Antiviral Therapy|November 21, 2007
Safety and immunogenicity from a phase I trial of inactivated severe acute respiratory syndrome coronavirus vaccineJiang-Tao Lin, Jian-San Zhang, Nan Su, et al.
Pageof 8

Showing results (71-80 of 75) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 75 results.
Vaccine|November 5, 2005
Preparation and characterization of SARS in-house reference antiserumJiansan Zhang, Yuxuan Liu, Liangxiang Hu, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|August 30, 2013
[Trastuzumab in combination with chemotherapy versus chemotherapy alone for first-line treatment of HER2-positive advanced gastric or gastroesophageal junction cancer: a Phase III, multi-center, randomized controlled trial, Chinese subreport]Lin Shen, Jian-ming Xu, Feng-yi Feng, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 27, 2007
Genome sequencing and comparative analysis of Saccharomyces cerevisiae strain YJM789Wu Wei, John H McCusker, Richard W Hyman, et al.
Vaccine|January 31, 2021
Recombinant SARS-CoV-2 RBD with a built in T helper epitope induces strong neutralization antibody responseQiu-Dong Su, Ye-Ning Zou, Yao Yi, et al.
Antiviral Therapy|November 21, 2007
Safety and immunogenicity from a phase I trial of inactivated severe acute respiratory syndrome coronavirus vaccineJiang-Tao Lin, Jian-San Zhang, Nan Su, et al.
Pageof 8